Oct 31, 2013

Posted by in Featured, Stock Market News | 0 Comments

Morning Gainers: NQ Mobile Inc (ADR) (NYSE:NQ), InvenSense Inc (NYSE:INVN), WuXi PharmaTech (NYSE:WX), CytoDyn (NASDAQ:CYDY)

Morning Gainers: NQ Mobile Inc (ADR) (NYSE:NQ), InvenSense Inc (NYSE:INVN), WuXi PharmaTech (NYSE:WX), CytoDyn (NASDAQ:CYDY)

CytoDyn (NASDAQ:CYDY) issues phase IIb protocol for PRO 140 clinical trial to FDA 1.33. CYDY declared that it has submitted a revised protocol to the US Food and Drug Administration relating to an upcoming Phase II b clinical trial of PRO 140, CytoDyn’s leading product under development as a treatment for Human Immunodeficiency Virus (HIV) infection.

NQ Mobile Inc (ADR) (NYSE:NQ) shares have lost 16.98% to $12.90. Over the last twelve months, the stock has gained 78.91% and past five days performance showed negative change of -44.01%. The stock daily volume was 8.14M as compared to average volume of 7.86M.

NQ Mobile Inc. (NQ), formerly NetQin Mobile Inc., is a holding company. The Company is a global provider of mobile Internet services focusing on security, privacy and productivity.

InvenSense Inc (NYSE:INVN) shares have lost -13.80% to $16.02. Over the last twelve months, the stock has gained 48.88% and past five days performance showed negative change of -13.5%. The stock daily volume was 6.62M as compared to average volume of 3.00M.

InvenSense, Inc. designs and fabricates micro-electro-mechanical systems (MEMS) technologies. Its solution is comprised of an integrated circuit (IC) that incorporates motions sensors such as gyroscopes with associated software.

WuXi PharmaTech (NYSE:WX) effectively finalizes its first 2000L disposable bioreactor run using an NSO cell line 29.43. The company declared that it had finished a cell culture capacity expansion, consisting of two 2000L disposable bioreactors that are ready for cGMP manufacturing.

Comments are closed.